Medulloblastoma in the second decade of life: A specific group with respect to toxicity and management-Reference-Cited by-同舟云学术

Medulloblastoma in the second decade of life: A specific group with respect to toxicity and management

Published:2005 Issue:9 Volume:103 Page:1874-1880
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Tabori Uri,Sung Lillian,Hukin Juliette,Laperriere Normand,Crooks Bruce,Carret Anne-Sophie,Silva Mariana,Odame Isaac,Mpofu Chris,Strother Douglas,Wilson Beverly,Samson Yvan,Bouffet Eric,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. The treatment of medulloblastoma

2. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the german prospective randomized trial hit ’91

3. Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study

4. Carboplatin and VP 16 in medulloblastoma: A phase II study of the French Society of Pediatric Oncology (sfop)

5. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International society of paediatric oncology (SIOP) and the (German) society of paediatric oncology (GPO): SIOP II

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute toxicity of chemotherapy in central nervous system germ cell tumour patients according to age;Frontiers in Oncology;2024-07-15

2. Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier;Cancer Medicine;2023-11-23

3. Central nervous system germ cell tumor, an archetypal AYA tumor and a model for pediatric and neuro-oncology collaboration, review from the EURACAN domain 10 group;Frontiers in Oncology;2022-09-29

4. Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline;Frontiers in Oncology;2022-09-23

5. Review of 20 years of adult medulloblastoma treatment: Chemotherapy prescription trends and survival;Neuro-Oncology Practice;2022-09-18